Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency
Top Cited Papers
- 1 May 2024
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 20 (8) , 487-500
Abstract
Polyuria–polydipsia syndrome can be caused by central diabetes insipidus, nephrogenic diabetes insipidus or primary polydipsia. To avoid confusion with diabetes mellitus, the name ‘central diabetes insipidus’ was changed in 2022 to arginine vasopressin (AVP) deficiency and ‘nephrogenic diabetes insipidus’ was renamed as AVP resistance. To differentiate the three entities, various osmotic and non-osmotic copeptin-based stimulation tests have been introduced in the past decade. The hypertonic saline test plus plasma copeptin measurement emerged as the test with highest diagnostic accuracy, replacing the water deprivation test as the gold standard in differential diagnosis of the polyuria–polydipsia syndrome. The mainstay of treatment for AVP deficiency is AVP replacement with desmopressin, a synthetic analogue of AVP specific for AVP receptor 2 (AVPR2), which usually leads to rapid improvements in polyuria and polydipsia. The main adverse effect of desmopressin is dilutional hyponatraemia, which can be reduced by regularly performing the so-called desmopressin escape method. Evidence from the past few years suggests an additional oxytocin deficiency in patients with AVP deficiency. This potential deficiency should be further evaluated in future studies, including feasible provocation tests for clinical practice and interventional trials with oxytocin substitution.Keywords
This publication has 135 references indexed in Scilit:
- Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcomePituitary, 2021
- Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteersPituitary, 2021
- Oxytocin alterations and neurocognitive domains in patients with hypopituitarismPituitary, 2019
- Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances2018
- Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3T MRI and between 2D-T1 spin-echo- and 3D-T1 gradient-echo sequencesPituitary, 2018
- Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjectsPsychopharmacology, 2017
- Oxytocin in survivors of childhood-onset craniopharyngiomaEndocrine, 2016
- Quality of life in the patients with central diabetes insipidus assessed by Nagasaki Diabetes Insipidus QuestionnaireEndocrine, 2015
- Copeptin: A novel, independent prognostic marker in patients with ischemic strokeAnnals of Neurology, 2009
- Changes in tissue sensitivity to vasopressin in hereditary hypothalamic diabetes insipidusJournal of Molecular Medicine, 1981